Socioeconomic Factors Associated with Lack of Treatment in Early Stage Non-Small Cell Lung Cancer

被引：7

作者：

Dalwadi, Shraddha M. ^{[1
]}

Zhang, Jun ^{[2
]}

Bernicker, Eric H. ^{[2
]}

Butler, E. Brian ^{[2
]}

Teh, Bin S. ^{[2
]}

Farach, Andrew M. ^{[2
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Houston Methodist Hosp, Houston, TX 77030 USA

来源：

CANCER INVESTIGATION | 2019年 / 37卷 / 09期

关键词：

Lung cancer; socioeconomic; access to care; radiation; surgery; STEREOTACTIC ABLATIVE RADIOTHERAPY; AFFORDABLE CARE ACT; SUBLOBAR RESECTION; ETHNIC DISPARITIES; RACIAL-DIFFERENCES; SURGICAL-TREATMENT; SURVIVAL; SURGERY; LOBECTOMY; OUTCOMES;

D O I：

10.1080/07357907.2019.1666136

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

With modern radiotherapy, stage I non-small cell lung cancer (S1NSCLC) cure is extended to nonsurgical candidates. Despite this, some S1NSCLC remains untreated. We aim to identify factors associated with no treatment. 62,213 S1NSCLC cases were identified (SEER: 2004-2012). Demographics were compared using Chi-squared. Multivariate analysis was performed using COX proportional HR. 11.9% of the 7373 patients lacked treatment. No insurance, Medicaid-dependence, unmarried status, advancing age, lower income, African American and Asian/Pacific Islander race, and male sex are associated with no treatment (p < .0001). No treatment portends a worse cancer-specific survival (21% vs 66% at 5Y, p < .0001) and OS (10% vs 50% at 5Y, p < .0001).

引用

页码：506 / 511

页数：6

共 50 条

[41] Prognostic factors in stage I non-small cell lung cancer
Passlick, B
Pantel, K
ZENTRALBLATT FUR CHIRURGIE, 1996, 121 (10): : 851 - 857
[42] Impact of cancer treatment on physical performance in early-stage non-small cell lung cancer
Quadflieg, Kirsten
Arents, Eva
Haesevoets, Sarah
Hermans, Fien
Criel, Maarten
Daenen, Marc
Ruttens, David
Thomeer, Michiel
Spruit, Martijn A.
Stevens, Dieter
Surmont, Veerle
Derom, Eric
Demeyer, Heleen
Burtin, Chris
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[43] Sublobar resection for early-stage non-small cell lung cancer and current advances with immunotherapy in multimodality treatment of resectable non-small cell lung cancer
Agrafiotis, Apostolos C.
Hendriks, Jeroen M. H.
Van Schil, Paul E.
AME SURGICAL JOURNAL, 2024, 4
[44] The efficacy and safety of thoracoscopic lobectomy in the treatment of early stage non-small cell lung cancer
Li, Weichun
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 88 - 88
[45] Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer
Kapadia, Nirav S.
Valle, Luca F.
George, Julie A.
Jagsi, Reshma
D'Amico, Thomas A.
Dexter, Elisabeth U.
Vigneau, Fawn D.
Kong, Feng Ming
ANNALS OF THORACIC SURGERY, 2017, 104 (06): : 1881 - 1888
[46] Surgical treatment of early stage non-small cell lung cancer by thoracoscopic segmental resection
Seguin-Givelet, A.
Lutz, J.
Brian, E.
Grigoroiu, M.
Gossot, D.
REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (05) : 521 - 530
[47] Patients' confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC)
Pompili, Cecilia
Holch, Patricia
Rogers, Zoe
Absolom, Kate
Clayton, Beverly
Franks, Kevin
Bekker, Hilary
Velikova, Galina
HEALTH AND QUALITY OF LIFE OUTCOMES, 2020, 18 (01)
[48] Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer
Klein, Mark
Pragman, Alexa A.
Wendt, Christine
SEMINARS IN ONCOLOGY, 2022, 49 (3-4) : 285 - 297
[49] Patients’ confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC)
Cecilia Pompili
Patricia Holch
Zoe Rogers
Kate Absolom
Beverly Clayton
Kevin Franks
Hilary Bekker
Galina Velikova
Health and Quality of Life Outcomes, 18
[50] Treatment of Early Stage Non-Small Cell Lung Cancer: Surgery or Stereotactic Ablative Radiotherapy?
Uzel, Esengul Kocak
Abacioglu, Ufuk
BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 8 - 16

← 1 2 3 4 5 →